Avita Medical, Inc. (RCEL) Financials
RCEL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 63.6 million | 42.3 million |
2023-12-31 | 76.1 million | 42.6 million |
2023-09-30 | 81.0 million | 18.0 million |
2023-06-30 | 86.0 million | 17.6 million |
RCEL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -14.4 million | 1.7 million |
2023-12-31 | -7.6 million | 1.5 million |
2023-09-30 | -9.5 million | 2.4 million |
2023-06-30 | -9.4 million | 1.1 million |
RCEL Net Income
No data available :(
RCEL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | - | - | 2.2 million |
2023-12-31 | - | - | 1.8 million |
2023-09-30 | 60.1 million | - | 1.8 million |
2023-06-30 | 65.8 million | - | 694610 |
RCEL Shares Outstanding
RCEL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 803522 | 3.4 million | 14.1 million | - |
2023-12-31 | 224829 | 4.6 million | 12.2 million | - |
2023-09-30 | 501966 | 4.4 million | 6.0 million | 10.5 million |
2023-06-30 | 297825 | 5.1 million | 5.9 million | 10.0 million |
RCEL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 7.3 million | 988397 |
2023-12-31 | 9.7 million | 1.2 million |
2023-09-30 | 13.6 million | 2.1 million |
2023-06-30 | 11.7 million | 2.2 million |
RCEL
Price: $8.27
52 week price:
Earnings Per Share: -1.40 USD
P/E Ratio: -13.04
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 159000
Market Capitalization: 213.4 million